The News Review:
- EP MedSystems’ Ultrasound Product Used in Heart Failure Treatment.
- New Method For Predicting Individual Patient Responses To Drug…
- Frederick community calendar
- Novel molecular ’signature’ marks DNA of embryonic stem cells
- PLT gains safety study for 5-Loxin
EP MedSystems’ Ultrasound Product Used in Heart Failure Treatment.
Free with registration - Business Wire - AccessMyLibrary.com - Apr 20, 2006
(NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, today announced that its ViewFlex(TM) ultrasound imaging catheter was used in a unique procedure to treat a patient in dysynchrony with heart failure. The procedure was performed by Sanjeev Saksena, MD, the Company’s Senior Medical Advisor. Dr Saksena is practicing cardiac electrophysiology and Clinical Professor of Medicine at the Robert Wood Johnson School of Medicine in New Brunswick, New Jersey. The procedure was successfully performed to resynchronize the left ventricle in a patient who previously had an implanted cardiac resynchronization pacemaker device, which had failed to improve heart function. Cardiac resynchronization therapy (CRT) is an innovative new therapy that can relieve heart failure symptoms by improving the coordination of the heart.
New Method For Predicting Individual Patient Responses To Drug…
Medical News Today - Apr 20, 2006
The authors anticipate that the development will advance biomedical research further towards development of personalised medicines. Research published today in Nature demonstrates the new ‘pharmaco-metabonomic’ approach that uses a combination of advanced chemical analysis and mathematical modelling to predict drug-induced responses in individual patients. The method is based on analysis of the body’s normal metabolic products, metabolites, and metabolite patterns that are characteristic of the individual. The authors hypothesize that these individual patterns can be used to diagnose diseases, predict an individual’s future illnesses, and their responses to treatments. Not all drugs are effective in all patients and in rare cases adverse drug reactions can occur in susceptible individuals. To address this, researchers from Imperial College and Pfizer have been exploring new methods for profiling individuals prior to drug therapy… The researchers hope this new technique might one day allow doctors to personalise drug treatments for some individuals, providing physicians with the ability to prescribe medicines that will be most effective for certain patient groups, and at a tailored dose-range for maximum efficacy and safety. Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (11,000) and staff (6,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture.
Frederick community calendar
Business Gazette - Apr 20, 2006
; National Museum of Civil War Medicine, 48 E. Includes a demonstration of Civil War-era surgical techniques and a discussion of the duties and experiences of Confederate surgeons… Short hike included; wear sturdy shoes and dress for the weather. Topics: natural and cultural history. 301-663-9388Basket bingo: 2 p. ; doors open at 12:30 p.
Novel molecular ’signature’ marks DNA of embryonic stem cells
EurekAlert - EurekAlert (press release) - Apr 20, 2006
”
Chromatin
Leave a Comment